Buy Price: $11.00 or better Sell Price: TradersPro Sell Signal INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient’s innate immune system to treat cancer Alzheimer’s disease, and non-alcoholic steatohepatitis. The company intends to develop and commercialize product candidates to treat hematologic malignancies and solid tumors. Its development programs include INKmune
Read MorePlus, the unemployment rate fell to 8.4% in August, the WHO said it doesn’t expect the world will see large-scale coronavirus vaccinations until mid-2021, and Peloton announced a new lower-priced treadmill and a new premium bike model.
Read MorePlus, Japanese Prime Minister Shinzo Abe is stepping down, House Speaker Pelosi said Democrats and Republicans are at a “tragic impasse” on coronavirus relief negotiations, Abbott Laboratories inked a deal with the U.S. government for 150 million of its rapid coronavirus antigen test.
Read MorePlus, Senate Republicans are planning to introduce a scaled back stimulus bill as the standoff with Democrats over a new virus relief plan continues, Quest Diagnostics sped up its coronavirus testing turnaround time, and three big retailers reported earnings.
Read MoreBuy Price: $2.25 or better Sell Price: TradersPro Sell Signal PAVmed Inc. operates as a medical device company in the United States. The company’s lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous […]
Read MoreTrade Setup Buy Target: $22.94 Sell Target: $26.07 Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is developing small molecule drug candidates primarily engineered to increase muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac […]
Read MoreBuy Price: $2.00 or better Sell Price: TradersPro Sell Signal CohBar, Inc., a clinical stage biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs) for the treatment of diseases associated with aging and metabolic dysfunction. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, type 2 diabetes […]
Read MorePlus, stimulus stocks continue to sputter, Eli Lilly is beginning a late stage trial of its experimental coronavirus antibody treatment in nursing homes, Microsoft has 45 days to finalize a deal to buy TikTok, and another electric vehicle maker is going public via a merger with a blank-check SPAC.
Read MorePlus, Delta Air Lines said it is cutting in half the number of flights it had planned to add next month as the coronavirus continues to roil flight demand, 3M has teamed up with MIT to develop a rapid coronavirus antigen test, Google is reportedly in talks to make a $4 billion in Indian telecom Jio Platforms, and Ford unveiled its new line of Bronco SUVs.
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreBuy Price: $19.75 or better Sell Price: TradersPro Sell Signal Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded […]
Read MorePlus, the EU won’t allow travelers from the U.S. as it reopens its external borders amid the surge of coronavirus cases, Wells Fargo is the only major bank reducing its quarterly dividend following the Fed’s latest stress test, and Royal Dutch Shell said it will write down as much as $22 billion in the second quarter.
Read MorePlus, coronavirus cases surpassed 10 million globally and 2.5 million in the U.S., Chesapeake Energy filed for bankruptcy, and Beyond Meat shares are down after a double downgrade.
Read MorePlus, Vice President Pence said the Trump administration is working with Democrats in “good faith” on another round of coronavirus stimulus, airline stocks are soaring as hopes rise of a recovery for air travel, and JCPenney announced it’s closing more than 150 stores following its bankruptcy filing last month.
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read More